A 4-year-old girl from Delhi presents on day 5 of illness with fever, cough, and a widespread maculopapular rash. Her parents report she had high fever (40°C) for 3 days, followed by rash onset. On examination, the rash is confluent on the face and upper trunk, with some blanching. She has cervical lymphadenopathy and hepatosplenomegaly. Her hemoglobin is 10.2 g/dL and platelet count is 80,000/μL. She was vaccinated with MMR at 12 months. What is the most likely complication she is at risk for?

Explanation

## Measles Complications: Immunosuppression and Secondary Infection Risk ### Clinical Context This patient has: - **Confirmed measles** (fever 3 days → rash on day 4–5, confluent maculopapular rash, cervical lymphadenopathy) - **Mild thrombocytopenia** (80,000/μL) — common in measles, usually self-limited - **Mild anemia** (10.2 g/dL) — consistent with acute viral illness - **Hepatosplenomegaly** — typical viral exanthem finding ### Measles-Associated Immunosuppression **High-Yield:** Measles causes **profound, transient immunosuppression** lasting weeks to months post-infection, mediated by: 1. **Infection of lymphoid tissues** (thymus, lymph nodes, spleen) → lymphocyte depletion 2. **Suppression of cell-mediated immunity** (Th1 shift to Th2) 3. **Impaired delayed-type hypersensitivity** — skin test anergy during acute measles 4. **Reduced antibody responses** to concurrent vaccinations **Clinical Pearl:** This immunosuppression explains the **"window of vulnerability"** — patients are at highest risk for secondary bacterial (pneumonia, otitis media, diarrhea) and opportunistic infections **during and for weeks after measles**. ### Complications of Measles: Timing and Risk | Complication | Timing | Mechanism | Incidence | |--------------|--------|-----------|----------| | **Pneumonia** (bacterial/viral) | During acute illness or 1–2 weeks post | Immunosuppression, direct viral damage | Most common (1–7%) | | **Otitis media** | During acute illness | Secondary bacterial infection | 5–15% | | **Diarrhea** | During acute illness | Viral enteritis + immunosuppression | 10% | | **Encephalitis (acute)** | Days 3–7 of rash | Direct viral invasion of CNS | 1 per 1000 | | **Subacute sclerosing panencephalitis (SSPE)** | 7–10 years post-infection | Defective viral replication in CNS | 4–11 per 100,000 | | **Measles inclusion body encephalitis (MIBE)** | Immunocompromised hosts only | Viral replication in CNS without immune response | Rare; immunocompromised only | **Key Point:** In an **immunocompetent child on day 5 of measles**, the immediate and near-term risk is **secondary bacterial superinfection** (pneumonia, otitis media, sinusitis, diarrhea) due to measles-induced immunosuppression. ### Why Not the Other Options? **DIC (Disseminated Intravascular Coagulation):** - Thrombocytopenia in measles is mild (usually 50,000–150,000/μL) and self-limited - Coagulation studies (PT, aPTT, fibrinogen) are typically normal - DIC is rare in uncomplicated measles; seen only in severe cases with hemorrhagic manifestations **MIBE (Measles Inclusion Body Encephalitis):** - Occurs **exclusively in severely immunocompromised patients** (e.g., advanced HIV, severe combined immunodeficiency) - This child has a normal immune response (mounted adequate antibody response post-MMR vaccination) - MIBE presents weeks to months post-measles, not acutely **SSPE (Subacute Sclerosing Panencephalitis):** - Occurs 7–10 years **after** measles infection, not during acute illness - Risk is higher in children infected before age 2 years - Presents with progressive neurological decline, not acute complications ### Management Implications **Mnemonic: SAFE** — **S**econdary infection prevention, **A**ntibiotics if bacterial superinfection suspected, **F**luids and nutrition, **E**ncephalitis/complications monitoring. **Key Point:** - Monitor for signs of **pneumonia** (tachypnea, hypoxia, chest infiltrates) - Administer **Vitamin A** (200,000 IU daily × 2 days, repeat at 2 weeks) to reduce severity and mortality - **Avoid antibiotics prophylactically** unless secondary infection develops - Educate parents on **isolation** (respiratory precautions until day 5 of rash) to prevent transmission